FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2517134098> ?p ?o ?g. }

• W2517134098 endingPage "2011" @default.
• W2517134098 startingPage "2002" @default.
• W2517134098 abstract "Rationale: Blood pressure reduction in response to antihypertensive agents is less for patients with obstructive sleep apnea (OSA). Increased sympathetic and inflammatory activity, as well as alterations in the renin–angiotensin–aldosterone system, may play a role in this context.Objectives: To address the cardiovascular mechanisms involved in response to an angiotensin II receptor antagonist, losartan, and continuous positive airway pressure (CPAP) as add-on treatment for hypertension and OSA.Methods: Newly diagnosed hypertensive patients with or without OSA (allocated in a 2:1 ratio for OSA vs. no OSA) were treated with losartan 50 mg daily during a 6-week two-center, open-label, prospective, case–control, parallel-design study. In the second 6-week, sex-stratified, open-label, randomized, parallel-design study, all subjects with OSA continued to receive losartan and were randomly assigned to either CPAP as add-on therapy or to no CPAP (1:1 ratio for CPAP vs. no CPAP). Study subjects without OSA were followed in parallel while they continued to take losartan. Blood samples were collected at baseline, after 6 weeks, and after 12 weeks for analysis of renin, aldosterone, noradrenaline, adrenaline, and inflammatory markers.Measurements and Main Results: Fifty-four patients with OSA and 35 without OSA were included in the first 6-week study. Losartan significantly increased renin levels and reduced aldosterone levels in the group without OSA. There was no significant decrease in aldosterone levels among patients with OSA. Add-on CPAP treatment tended to lower aldosterone levels, but reductions were more pronounced in measures of sympathetic activity. No significant changes in inflammatory markers were observed following treatment with losartan and CPAP.Conclusions: Hypertensive patients with OSA responded to losartan treatment with smaller reductions in aldosterone compared with hypertensive patients without OSA. Sympathetic system activity seemed to respond primarily to add-on CPAP treatment in patients with newly discovered hypertension and OSA.Clinical trial registered with www.clinicaltrials.gov (NCT00701428)." @default.
• W2517134098 created "2016-09-16" @default.
• W2517134098 creator A5004937795 @default.
• W2517134098 creator A5040085770 @default.
• W2517134098 creator A5044731910 @default.
• W2517134098 creator A5055200248 @default.
• W2517134098 creator A5073156703 @default.
• W2517134098 creator A5085233379 @default.
• W2517134098 date "2016-11-01" @default.
• W2517134098 modified "2023-10-18" @default.
• W2517134098 title "Neuroendocrine and Inflammatory Responses to Losartan and Continuous Positive Airway Pressure in Patients with Hypertension and Obstructive Sleep Apnea. A Randomized Controlled Trial" @default.
• W2517134098 cites W129344116 @default.
• W2517134098 cites W1832272867 @default.
• W2517134098 cites W1979742611 @default.
• W2517134098 cites W1984016637 @default.
• W2517134098 cites W1985026594 @default.
• W2517134098 cites W1985120228 @default.
• W2517134098 cites W2002557448 @default.
• W2517134098 cites W2018804515 @default.
• W2517134098 cites W2024431022 @default.
• W2517134098 cites W2033454597 @default.
• W2517134098 cites W2033706746 @default.
• W2517134098 cites W2039634178 @default.
• W2517134098 cites W2050863893 @default.
• W2517134098 cites W2051783375 @default.
• W2517134098 cites W2058153849 @default.
• W2517134098 cites W2058939989 @default.
• W2517134098 cites W2062457313 @default.
• W2517134098 cites W2063851257 @default.
• W2517134098 cites W2073271501 @default.
• W2517134098 cites W2075735790 @default.
• W2517134098 cites W2076462334 @default.
• W2517134098 cites W2086111363 @default.
• W2517134098 cites W2092315610 @default.
• W2517134098 cites W2099155891 @default.
• W2517134098 cites W2111474247 @default.
• W2517134098 cites W2114453846 @default.
• W2517134098 cites W2118826211 @default.
• W2517134098 cites W2119080429 @default.
• W2517134098 cites W2128416574 @default.
• W2517134098 cites W2140058549 @default.
• W2517134098 cites W2142179136 @default.
• W2517134098 cites W2149011983 @default.
• W2517134098 cites W2163408606 @default.
• W2517134098 cites W2165384819 @default.
• W2517134098 cites W2226689849 @default.
• W2517134098 cites W2333769075 @default.
• W2517134098 cites W4236805817 @default.
• W2517134098 cites W4294915483 @default.
• W2517134098 doi "https://doi.org/10.1513/annalsats.201602-126oc" @default.
• W2517134098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27548072" @default.
• W2517134098 hasPublicationYear "2016" @default.
• W2517134098 type Work @default.
• W2517134098 sameAs 2517134098 @default.
• W2517134098 citedByCount "9" @default.
• W2517134098 countsByYear W25171340982017 @default.
• W2517134098 countsByYear W25171340982018 @default.
• W2517134098 countsByYear W25171340982020 @default.
• W2517134098 countsByYear W25171340982022 @default.
• W2517134098 countsByYear W25171340982023 @default.
• W2517134098 crossrefType "journal-article" @default.
• W2517134098 hasAuthorship W2517134098A5004937795 @default.
• W2517134098 hasAuthorship W2517134098A5040085770 @default.
• W2517134098 hasAuthorship W2517134098A5044731910 @default.
• W2517134098 hasAuthorship W2517134098A5055200248 @default.
• W2517134098 hasAuthorship W2517134098A5073156703 @default.
• W2517134098 hasAuthorship W2517134098A5085233379 @default.
• W2517134098 hasConcept C126322002 @default.
• W2517134098 hasConcept C134018914 @default.
• W2517134098 hasConcept C164705383 @default.
• W2517134098 hasConcept C168563851 @default.
• W2517134098 hasConcept C198710026 @default.
• W2517134098 hasConcept C2776006263 @default.
• W2517134098 hasConcept C2777935920 @default.
• W2517134098 hasConcept C2778525890 @default.
• W2517134098 hasConcept C2779547634 @default.
• W2517134098 hasConcept C2780288358 @default.
• W2517134098 hasConcept C2908929049 @default.
• W2517134098 hasConcept C71924100 @default.
• W2517134098 hasConcept C84393581 @default.
• W2517134098 hasConceptScore W2517134098C126322002 @default.
• W2517134098 hasConceptScore W2517134098C134018914 @default.
• W2517134098 hasConceptScore W2517134098C164705383 @default.
• W2517134098 hasConceptScore W2517134098C168563851 @default.
• W2517134098 hasConceptScore W2517134098C198710026 @default.
• W2517134098 hasConceptScore W2517134098C2776006263 @default.
• W2517134098 hasConceptScore W2517134098C2777935920 @default.
• W2517134098 hasConceptScore W2517134098C2778525890 @default.
• W2517134098 hasConceptScore W2517134098C2779547634 @default.
• W2517134098 hasConceptScore W2517134098C2780288358 @default.
• W2517134098 hasConceptScore W2517134098C2908929049 @default.
• W2517134098 hasConceptScore W2517134098C71924100 @default.
• W2517134098 hasConceptScore W2517134098C84393581 @default.
• W2517134098 hasIssue "11" @default.
• W2517134098 hasLocation W25171340981 @default.
• W2517134098 hasLocation W25171340982 @default.
• W2517134098 hasOpenAccess W2517134098 @default.
• W2517134098 hasPrimaryLocation W25171340981 @default.

• next